Gene · 1633
Papers2,658
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,658
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Therapeutic Advances in Multiple Sclerosis. | Front Neurol | 2022 | 35720070 | PubTator, text mining | PubMed |
| Investigating the Anticancer Potential of Salvicine as a Modulator of Topoisomerase II and ROS Signaling Cascade. | Front Oncol | 2022 | 35719997 | PubTator, text mining | PubMed |
| E2F2 enhances the chemoresistance of pancreatic cancer to gemcitabine by regulating the cell cycle and upregulating the expression of RRM2. | Med Oncol | 2022 | 35716217 | PubTator, text mining | PubMed |
| Hallmarks of DNA replication stress. | Mol Cell | 2022 | 35714587 | PubTator, text mining | PubMed |
| Multiple Sclerosis: Therapeutic Strategies on the Horizon. | Cureus | 2022 | 35706718 | PubTator, text mining | PubMed |
| Advances in the systemic treatment of therapeutic approaches in biliary tract cancer. | ESMO Open | 2022 | 35696747 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| A pyroptosis-related gene signature predicts prognosis and immune microenvironment in hepatocellular carcinoma. | World J Surg Oncol | 2022 | 35659304 | PubTator, text mining | PubMed |
| Antiproliferative and apoptotic activity of gemcitabine-lauric acid conjugate on human bladder cancer cells. | Iran J Basic Med Sci | 2022 | 35656081 | PubTator, text mining | PubMed |
| Purine nucleoside phosphorylase enables dual metabolic checkpoints that prevent T cell immunodeficiency and TLR7-associated autoimmunity. | J Clin Invest | 2022 | 35653193 | PubTator, text mining | PubMed |
| Role of the Pro-Inflammatory Tumor Microenvironment in Extracellular Vesicle-Mediated Transfer of Therapy Resistance. | Front Oncol | 2022 | 35646668 | PubTator, text mining | PubMed |
| Epigenetic Silencing of PTEN and Epi-Transcriptional Silencing of MDM2 Underlied Progression to Secondary Acute Myeloid Leukemia in Myelodysplastic Syndrome Treated with Hypomethylating Agents. | Int J Mol Sci | 2022 | 35628480 | PubTator, text mining | PubMed |
| Neurotoxicity Associated with Treatment of Acute Lymphoblastic Leukemia Chemotherapy and Immunotherapy. | Int J Mol Sci | 2022 | 35628334 | PubTator, text mining | PubMed |
| Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review. | Cancers (Basel) | 2022 | 35626089 | PubTator, text mining | PubMed |
| Radionuclide Imaging of Cytotoxic Immune Cell Responses to Anti-Cancer Immunotherapy. | Biomedicines | 2022 | 35625811 | PubTator, text mining | PubMed |
| Acquired chemoresistance drives spatial heterogeneity, chemoprotection and collective migration in pancreatic tumor spheroids. | PLoS One | 2022 | 35617275 | PubTator, text mining | PubMed |
| Changing paradigms in oncology: Toward noncytotoxic treatments for advanced gliomas. | Int J Cancer | 2022 | 35603902 | PubTator, text mining | PubMed |
| Cancer genomic profiling identified dihydropyrimidine dehydrogenase deficiency in bladder cancer promotes sensitivity to gemcitabine. | Sci Rep | 2022 | 35595780 | PubTator, text mining | PubMed |
| Exosomes and their roles in the chemoresistance of pancreatic cancer. | Cancer Med | 2022 | 35587712 | PubTator, text mining | PubMed |
| c-Myc-PD-L1 Axis Sustained Gemcitabine-Resistance in Pancreatic Cancer. | Front Pharmacol | 2022 | 35586061 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1633/papers?page=17